TCTP is an androgen-regulated gene implicated in prostate cancer

PLoS One. 2013 Jul 22;8(7):e69398. doi: 10.1371/journal.pone.0069398. Print 2013.

Abstract

TCTP has been implicated in a plethora of important cellular processes related to cell growth, cell cycle progression, malignant transformation and inhibition of apoptosis. In addition to these intracellular functions, TCTP has extracellular functions and plays an important role in immune cells. TCTP expression was previously shown to be deregulated in prostate cancer, but its function in prostate cancer cells is largely unknown. Here we show that TCTP expression is regulated by androgens in LNCaP prostate cancer cells in vitro as well as human prostate cancer xenografts in vivo. Knockdown of TCTP reduced colony formation and increased apoptosis in LNCaP cells, implicating it as an important factor for prostate cancer cell growth. Global gene expression profiling in TCTP knockdown LNCaP cells showed that several interferon regulated genes are regulated by TCTP, suggesting that it may have a role in regulating immune function in prostate cancer. In addition, recombinant TCTP treatment increased colony formation in LNCaP cells suggesting that secreted TCTP may function as a proliferative factor in prostate cancer. These results suggest that TCTP may have a role in prostate cancer development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androgens / pharmacology*
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Biomarkers, Tumor / deficiency
  • Biomarkers, Tumor / genetics*
  • Biomarkers, Tumor / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Cell Survival / genetics
  • Cell Transformation, Neoplastic
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Gene Knockdown Techniques
  • Humans
  • Male
  • Mice
  • Neoplastic Stem Cells / drug effects
  • Neoplastic Stem Cells / pathology
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / pathology
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Recombinant Proteins / pharmacology
  • Tumor Protein, Translationally-Controlled 1

Substances

  • Androgens
  • Biomarkers, Tumor
  • Recombinant Proteins
  • TPT1 protein, human
  • Tpt1 protein, mouse
  • Tumor Protein, Translationally-Controlled 1

Grants and funding

This work has been supported by grants from the Norwegian Research Council (Grant #193337/V50, www.forskningsradet.no) and Norwegian Cancer Society (Grant #71395 - PR-2006-0335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.